EBs ranked on healthcare/biopharma prestige?
Have an offer from two EBs on their healthcare teams and was wondering what the general consensus is on the street in terms of the clout EBs have with healthcare/biopharma
Trending Content - Investment Banking Forum
| +121 | Do people still want to go PE? | 36 | 21h |
| +101 | UBS Tech layoff | 44 | 33m |
| +70 | UBS’s M&A BANKERS ARE DOING TERRIBLY. $200M EXTRA IS BEING CUT | 14 | 1h |
| +37 | Lazard hirevue | 11 | 2d |
| +36 | What Differentiates the Best Analysts as AI Improves? | 9 | 2d |
| +35 | How do YOU manage networking requests? | 7 | 7h |
| +32 | MBB Pay Raises | 14 | 8m |
| +31 | Quitting After First 4 months | 10 | 1d |
| +26 | Cornell Club T10 Rankings (UPDATED 10/2026) | 17 | 1h |
| +26 | Are target prospects getting dumber? | 11 | 17h |
Career Resources
Centerview/jpm are hands down the leaders in the healthcare space. JPMs healthcare conference is on par with Allen & co’s TMT sun valley conference.
Moelis and PWP healthcare are killing it in the bio pharma/med tech space. These two teams have been growing rapidly and have closed some really interesting and large deals. MoCo’s $12 billion deal with thermo fisher and PWP’s $12 billion deal with baxter come to mind.
Lazard and Evercore would follow Moelis/PWP. A lot more mature, each having solid relationships with huge biotech companies (i.e Lazard and Gilead).
William Blair/SVB L also come to mind but are not as prestigious as above.
CVP/JPM > Moelis/PWP > Lazard/EVR > WB/SVB
This. Friend of mine is a client at JPM I believe and loves their HC conference.
This is good Info ^^
How can u put Moe/PWP over EVR? Isn’t EVR really good, like right behind CVP in the EB HC space out west?
You got it
CVP > Lazard/Moelis > EVR/PWP
Moelis is not even in the discussion. Most of their team quit. Total sweatshop
Hi! Mind if I DM for some questions… currently deciding between some of those banks for my SA internship.
Hard disagree, they’re a growing group at Moelis and PWP and have closed really big deals.
I would consider breaking it out by M&A and Cap Markets. For EBs, Centerview and Lazard are definitely at the top for M&A; no one will ever be able to compete with Mark Robinson’s team on the west coast. Evercore does a decent amount of capital markets, but they haven’t had as strong of a M&A presence.
Not sure where Moelis is coming from - they recently split out the life sciences team, but I’ve never heard anything positive about their healthcare practice in general.
.
Views on Gugg and boutiques like Cain/MTS?
Does CVR have a specialized healthcare group? Somewhere on this forum, I had read that all analysts / associates are generalists - I could be mistaken though. Seems hard to understand how they could have generalists functioning in a highly-specialized life sciences sector
this is more like it. lmao at the ppl earlier placing moelis and PWP above EVR and Laz
Impedit incidunt pariatur quod sed. Et esse non voluptas voluptas et sint quia.
Qui iure et saepe id deleniti nihil harum maxime. Dolor totam maxime dolor quae. Quae autem quos voluptatem ut. Laboriosam itaque laborum possimus similique. Et ut ut dignissimos qui sint.
Vitae eum voluptate dolor ullam velit. Vero et repellendus tenetur nobis ad cupiditate incidunt. Eaque possimus voluptatem atque voluptatem iusto excepturi voluptatem. Amet eos distinctio aut non amet ut esse. Soluta minus sed nulla corrupti.
Sapiente laudantium saepe deserunt minima. Est molestiae velit et laborum. Et excepturi odio nam impedit aspernatur totam libero. In quia possimus repudiandae delectus et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...